Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: Diagnosis, treatment, and improved quality of life

Journal of General Internal Medicine

Volumn 23, Issue 6, 2008, Pages 875-878

  Coe, Susan G ^a   Tan, Winston W ^a   Fox, Thomas P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Carcinoid; Corticotropin; Cushing's disease; Cushing's syndrome; Ectopic adrenocorticotropic hormone; Neuroendocrine tumor

Indexed keywords

CORTICOTROPIN; OCTREOTIDE;

ADULT; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER CARCINOMA; LIVER INJURY; QUALITY OF LIFE; URINALYSIS;

EID: 43949114494     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0587-z     Document Type: Article

References (20)

1. 1. LK Nieman I Ilias 2005 Evaluation and treatment of Cushing’s syndrome Am J Med 118 12 1340 6 16378774 10.1016/j.amjmed.2005.01.059 Nieman LK, Ilias I. Evaluation and treatment of Cushing’s syndrome. Am J Med. 2005;118(12):1340–6.
2. 2. EJ Ross DC Linch 1982 Cushing’s syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis Lancet 2 8299 646 9 6125785 10.1016/S0140-6736(82)92749-0 1:STN:280:DyaL383ntV2ltg%3D%3D Ross EJ, Linch DC Cushing’s syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet. 1982;2(8299):646–9.
3. 3. I Ilias 2005 Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health J Clin Endocrinol Metab 90 8 4955 62 15914534 10.1210/jc.2004-2527 1:CAS:528:DC%2BD2MXnvVWksbw%3D Ilias I, et al. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90(8):4955–62.
4. 4. JA Whitworth 2005 Cardiovascular consequences of cortisol excess Vasc Health Risk Manag 1 4 291 9 17315601 10.2147/vhrm.2005.1.4.291 1:CAS:528:DC%2BD28XhtFSisrfL Whitworth JA, et al. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag. 2005;1(4):291–9.
5. 5. G Arnaldi 2003 Diagnosis and complications of Cushing’s syndrome: a consensus statement J Clin Endocrinol Metab 88 12 5593 602 14671138 10.1210/jc.2003-030871 1:CAS:528:DC%2BD3sXhtVShu7fL Arnaldi G, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88(12):5593–602.
6. 6. LF Kirk Jr 1133 Cushing’s disease: clinical manifestations and diagnostic evaluation Am Fam Phys 62 5 1119 27 Kirk LF Jr, et al. Cushing’s disease: clinical manifestations and diagnostic evaluation. Am Fam Phys. 1133;62(5):1119–27.
7. 7. Nieman LK. Establishing the diagnosis of Cushing’s syndrome. Available from: http://uptodateonline.com/utd/content/topic.do?topicKey=adrenal/2346&selectedTitle=3∼150&source=search_result. Accessed 5 March 2008.
8. 8. JR Lindsay LK Nieman 2005 Differential diagnosis and imaging in Cushing’s syndrome Endocrinol Metab Clin North Am 34 2 403 21 15850850 10.1016/j.ecl.2005.01.009 1:CAS:528:DC%2BD2MXltlOmsLc%3D Lindsay JR, Nieman LK. Differential diagnosis and imaging in Cushing’s syndrome. Endocrinol Metab Clin North Am. 2005;34(2):403–21.
9. 9. RG Robertson WJ Geiger NB Davis 2006 Carcinoid tumors Am Fam Phys 74 3 429 34 Robertson RG, Geiger WJ, Davis NB. Carcinoid tumors. Am Fam Phys. 2006;74(3)429–34.
10. 10. DJ Torpy 2002 Association of hypertension and hypokalemia with Cushing’s syndrome caused by ectopic ACTH secretion: a series of 58 cases Ann N Y Acad Sci 970 134 44 12381548 1:CAS:528:DC%2BD38XovFaluro%3D 10.1111/j.1749-6632.2002.tb04419.x Torpy DJ, et al. Association of hypertension and hypokalemia with Cushing’s syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci. 2002;970:134–44.
11. 11. T Anthony L Kim 2002 Gastrointestinal carcinoid tumors and the carcinoid syndrome, 7th ed M Feldman LS Friedman M Sleisenger Sleisenger and Fordtran’s Gastrointestinal and Liver Diseases: Pathophysiology, Diagnosis, Management, Vol. 2 Saunders Philadelphia 2151 68 Anthony T, Kim L. Gastrointestinal carcinoid tumors and the carcinoid syndrome, 7th ed. In: Feldman M, Friedman LS, Sleisenger M, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Diseases: Pathophysiology, Diagnosis, Management, Vol. 2. Philadelphia: Saunders; 2002:2151–68.
12. 12. AM Isidori 2006 The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up J Clin Endocrinol Metab 91 2 371 7 16303835 10.1210/jc.2005-1542 1:CAS:528:DC%2BD28XhsFKnt70%3D Isidori AM, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab. 2006;91(2):371–7.
13. 13. JP Aniszewski 2001 Cushing syndrome due to ectopic adrenocorticotropic hormone secretion World J Surg 25 7 934 40 11572035 10.1007/s00268-001-0032-5 1:STN:280:DC%2BD3MrisVGitw%3D%3D Aniszewski JP, et al. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg. 2001;25(7):934–40.
14. 14. NA Shah 2007 Primary hepatic carcinoid tumor presenting as Cushing’s syndrome J Endocrinol Invest 30 4 327 33 17556871 1:CAS:528:DC%2BD2sXot1CktLg%3D Shah NA, et al. Primary hepatic carcinoid tumor presenting as Cushing’s syndrome. J Endocrinol Invest. 2007;30(4):327–33.
15. 15. EA Woltering 2005 Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors Pancreas 31 4 392 400 16258376 10.1097/01.mpa.0000186249.89081.0d 1:CAS:528:DC%2BD2MXht1OjurfE Woltering EA, et al. Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors. Pancreas. 2005;31(4):392–400.
16. 16. JM Sarmiento 2003 Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival J Am Coll Surg 197 1 29 37 12831921 10.1016/S1072-7515(03)00230-8 Sarmiento JM, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197(1):29–37.
17. 17. JM Sarmiento FG Que 2003 Hepatic surgery for metastases from neuroendocrine tumors Surg Oncol Clin N Am 12 1 231 42 12735141 10.1016/S1055-3207(02)00076-5 Sarmiento JM, Que FG. Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am. 2003;12(1):231–42.
18. 18. AE Siperstein E Berber 2001 Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases World J Surg 25 6 693 6 11376399 10.1007/s00268-001-0015-6 1:STN:280:DC%2BD3M3ps12gtw%3D%3D Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg. 2001;25(6):693–6.
19. 19. AK Mishra 2007 Outcome of adrenalectomy for Cushing’s syndrome: experience from a tertiary care center World J Surg 31 7 1425 32 17534556 10.1007/s00268-007-9067-6 Mishra AK, et al. Outcome of adrenalectomy for Cushing’s syndrome: experience from a tertiary care center. World J Surg. 2007;31(7):1425–32.
20. 20. DS O’Riordain 1994 Long-term outcome of bilateral adrenalectomy in patients with Cushing’s syndrome Surgery 116 6 1088 93 7985092 1:STN:280:ByqD2snjs1M%3D discussion 1093–4 O’Riordain DS, et al. Long-term outcome of bilateral adrenalectomy in patients with Cushing’s syndrome. Surgery. 1994;116(6):1088–93. discussion 1093–4.